In our research, we confirmed that HE4 expression was up-regulated in the lung tissue and peripheral blood plasma of COPD patients relative to healthy controls, and plasma HE4 presented distinct negative association with lung function, indirectly suggesting the possible role of HE4 in COPD pathogenesis and inflammation. The gene discussed is WFDC2; the disease is chronic obstructive pulmonary disease.